BCKDE1A Activators
BCKDE1A activators belong to a specialized class of chemical compounds designed to modulate the activity of the BCKDE1A enzyme, which plays a crucial role in cellular metabolism. BCKDE1A, or Branched-Chain Ketoacid Dehydrogenase E1 Alpha, is a key component of the branched-chain amino acid (BCAA) metabolic pathway. This enzyme is primarily responsible for catalyzing the first step in the degradation of branched-chain amino acids, including valine, leucine, and isoleucine. The BCAA catabolic pathway is essential for maintaining the appropriate balance of amino acids in the body, as well as providing energy and carbon skeletons for various metabolic processes. BCKDE1A activators, therefore, have the potential to influence this critical metabolic pathway, impacting the breakdown of BCAAs and the subsequent utilization of their metabolic products.
The study of BCKDE1A activators is of significant importance in the field of biochemistry and metabolism. These activators have the potential to modulate the activity of BCKDE1A, which could affect the rate at which branched-chain amino acids are metabolized. This modulation can have implications for cellular energy production, amino acid homeostasis, and overall metabolic balance. Understanding the molecular mechanisms behind BCKDE1A activation and its impact on the BCAA catabolic pathway is crucial for unraveling the complexities of cellular metabolism and may have applications in metabolic disorders and nutritional science. Additionally, the development of BCKDE1A activators could provide valuable tools for researchers studying the intricacies of metabolic pathways and exploring potential interventions for conditions related to imbalances in amino acid metabolism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
As one of the BCAAs, elevated levels of leucine might act as a feedback to upregulate BCKDE1A expression for increased catabolism. | ||||||
L-Isoleucine | 73-32-5 | sc-396706 sc-396706A | 25 g 100 g | $28.00 $120.00 | ||
Another BCAA; its abundance might induce BCKDE1A expression due to increased need for catabolism. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Known to modulate various metabolic pathways, potentially affecting BCAA metabolism and BCKDE1A expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 is involved in various metabolic processes. Its activation might influence BCKDE1A expression as part of broader metabolic regulation. | ||||||
Glucagon trifluoroacetic acid salt | 9007-92-5 (free base) | sc-495801 | 1 mg | $480.00 | ||
Known to regulate glucose and lipid metabolism. Changes in these pathways might indirectly influence BCAA catabolism and BCKDE1A expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Has broad effects on metabolic pathways, potentially influencing BCKDE1A expression in the context of BCAA metabolism. | ||||||